India Generics Exports To Rise 14-16% Next Five Years, Expert Says
This article was originally published in PharmAsia News
Executive Summary
A research group expects India’s generics makers to see as much as a 16% increase in exports over the next five years, partly because research-and-development efforts by multinational national drug makers have produced meager results.
A research group expects India’s generics makers to see as much as a 16% increase in exports over the next five years, partly because research-and-development efforts by multinational national drug makers have produced meager results. Crisil Research notes $150 billion worth of drugs will have lost patent protection between 2010 and 2015, spurring the growth prospects for India’s generics makers and luring more companies into the business in the near future. But it noted that along with added competition, the prices of generics can expect concomitant erosion. (Click here for more
)
“Future Of Indian Pharma Lies Beyond Generics” – The Hindu (India) (4/22/12)